Columbia University Irving Cancer Center — New York, New York

Columbia University Irving Cancer Center is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Columbia University Irving Cancer Center has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Prostate Cancer, Metastatic Castration-resistant Prostate Cancer.

Sponsors: Weill Medical College of Cornell University, OncoC4, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University Irving Cancer Center?

Columbia University Irving Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University Irving Cancer Center conducted?

Columbia University Irving Cancer Center has 2 clinical trials on record, with 2 currently active. Their work covers Prostate Cancer, Metastatic Castration-resistant Prostate Cancer.

Is Columbia University Irving Cancer Center accredited by Crixeo Health?

Columbia University Irving Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia University Irving Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.